EUVIMEDEUVIMED entdecken
Crossref

Comparison of Sugammadex and Neostigmine/Glycopyrrolate in Reversing Neuromuscular Blockade in Adults Using Neuromuscular Monitor

Kallol Ganguly, Prithviraj Chakraverty, Subhashis Saha, Debjani Gupta

International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)

DOI: 10.25258/ijcpr.18.6.7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Kallol Ganguly und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neostigmine, the conventional agent for neuromuscular blockade reversal, acts indirectly by inhibiting acetylcholinesterase and is associated with unpredictable recovery times and muscarinic side effects. Sugammadex, a modified γ-cyclodextrin, reverses steroidal neuromuscular blocking agents by direct encapsulation, offering the potential for rapid and predictable reversal. While prior studies demonstrated its efficacy in deep blockade, evidence comparing both agents in moderate blockade under inhalational anaesthesia was limited.

Methods

One hundred twenty patients, of either sex, ASA physical status I or II, undergoing elective Laparoscopic cholecystectomy under general anaesthesia, were randomly allocated into two groups containing sixty patients each. Group A received Sugammadex for Reversal of muscle relaxant and Group B received Neostigmine/Glycopyrrolate for Reversal of Muscle Relaxant.

Results

Sugammadex achieved TOF ≥ 0.9 significantly faster than Neostigmine (89 second versus 399 second, P < 0.0001). 98% of patients receiving Sugammadex recovered within 2 minutes showing greater predictability, while with neostigmine some patients required more than 7 minutes to recover.

Conclusion

Sugammadex provides markedly faster, more predictable, and reliable reversal of moderate rocuronium-induced neuromuscular blockade compared with neostigmine during sevoflurane anaesthesia, with a comparable safety profile.

Zitieren

APA

Ganguly, K., Chakraverty, P., Saha, S., & Gupta, D. (2026). Comparison of Sugammadex and Neostigmine/Glycopyrrolate in Reversing Neuromuscular Blockade in Adults Using Neuromuscular Monitor. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.7

Vancouver

Ganguly K, Chakraverty P, Saha S, Gupta D. Comparison of Sugammadex and Neostigmine/Glycopyrrolate in Reversing Neuromuscular Blockade in Adults Using Neuromuscular Monitor. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.7

BibTeX
@article{Ganguly2026,
  author = {Ganguly, Kallol and Chakraverty, Prithviraj and Saha, Subhashis and Gupta, Debjani},
  title = {Comparison of Sugammadex and Neostigmine/Glycopyrrolate in Reversing Neuromuscular Blockade in Adults Using Neuromuscular Monitor},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {06},
  doi = {10.25258/ijcpr.18.6.7}
}
Kostenlos starten →